Concepedia

Larry M. Weiskirch

LM

Statistics

Publications

4

Citations

183

H-Index

4

Active since

1989

Affiliations

University of Pennsylvania(Current)

University of Illinois Chicago

Larry M. Weiskirch is an author at University of Pennsylvania specializing in cancer immunology, oncology, and immunology.

Publications per year

1989–2001

4

Publications

4

Regression of established B16F10 melanoma with a recombinant Listeria monocytogenes vaccine.

Zhen-Kun Pan, Larry M. Weiskirch, Yvonne Paterson · PubMed · 1999 · 92 citations

, , +17

Transforming growth factor-?-mediated down-regulation of antitumor cytotoxicity of spleen cells from MOPC-315 tumor-bearing mice engaged in tumor eradication following low-dose melphalan therapy

Larry M. Weiskirch, Yifat Bar-Dagan, Margalit B. Mokyr · Cancer Immunology Immunotherapy · 1994 · 37 citations · Full text

, , +16

Importance of Lyt 2+ T-cells in the curative effectiveness of a low dose of melphalan for mice bearing a large MOPC-315 tumor.

Margalit B. Mokyr, Edward Barker, Larry M. Weiskirch et al. · PubMed · 1989 · 36 citations

, , +13

The Tumor Recall Response of Antitumor Immunity Primed by a Live, Recombinant Listeria monocytogenes Vaccine Comprises Multiple Effector Mechanisms

Larry M. Weiskirch, Zhen-Kun Pan, Yvonne Paterson · Clinical Immunology · 2001 · 18 citations

, , +14

1–4 of 4